AAAAAA

   
Results: 1-8 |
Results: 8
In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients
Authors: Albertini, MR King, DM Newton, MA Vacek, PM
Citation: Mr. Albertini et al., In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients, MUT RES-F M, 476(1-2), 2001, pp. 83-97
Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding gp100 and granulocyte-macrophage colony-stimulating factor
Authors: Rakhmilevich, AL Imboden, M Hao, ZL Macklin, MD Roberts, T Wright, KM Albertini, MR Yang, NS Sondel, PM
Citation: Al. Rakhmilevich et al., Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding gp100 and granulocyte-macrophage colony-stimulating factor, CLIN CANC R, 7(4), 2001, pp. 952-961
B7.1 expression eliminates tumor resistance to IL-12 gene therapy
Authors: Heise, CP Shi, FS Albertini, MR Mahvi, DM
Citation: Cp. Heise et al., B7.1 expression eliminates tumor resistance to IL-12 gene therapy, CANC GENE T, 8(2), 2001, pp. 118-127
Donor-derived small cell lung carcinoma in a kidney transplant recipient
Authors: Bodvarsson, S Burlingham, W Kusaka, S Hafez, GR Becker, BN Pintar, T Sollinger, HW Albertini, MR
Citation: S. Bodvarsson et al., Donor-derived small cell lung carcinoma in a kidney transplant recipient, CANCER, 92(9), 2001, pp. 2429-2434
Central venous device-related infection and thrombosis in patients treatedwith moderate dose continuous-infusion interleukin-2
Authors: Eastman, ME Khorsand, M Maki, DG Williams, EC Kim, K Sondel, PM Schiller, JH Albertini, MR
Citation: Me. Eastman et al., Central venous device-related infection and thrombosis in patients treatedwith moderate dose continuous-infusion interleukin-2, CANCER, 91(4), 2001, pp. 806-814
Dermatomyositis after interferon alpha treatment
Authors: Dietrich, LL Bridges, AJ Albertini, MR
Citation: Ll. Dietrich et al., Dermatomyositis after interferon alpha treatment, MED ONCOL, 17(1), 2000, pp. 64-69
Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression
Authors: McCarthy, DO Glowacki, N Schell, K Emler, CA Albertini, MR
Citation: Do. Mccarthy et al., Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression, CANCER IMMU, 49(2), 2000, pp. 85-93
Preclinical development of human granulocyte-macrophage colony-stimulatingfactor-transfected melanoma cell vaccine using established canine cell lines and normal dogs
Authors: Hogge, GS Burkholder, JK Culp, J Albertini, MR Dubielzig, RR Yang, NS MacEwen, EG
Citation: Gs. Hogge et al., Preclinical development of human granulocyte-macrophage colony-stimulatingfactor-transfected melanoma cell vaccine using established canine cell lines and normal dogs, CANC GENE T, 6(1), 1999, pp. 26-36
Risultati: 1-8 |